222 related articles for article (PubMed ID: 16107944)
1. CD4 lymphocyte percentage versus absolute CD4 lymphocyte count in predicting HIV disease progression: an old debate revisited.
Goicoechea M; Haubrich R
J Infect Dis; 2005 Sep; 192(6):945-7. PubMed ID: 16107944
[No Abstract] [Full Text] [Related]
2. CD4 lymphocyte percentage predicts disease progression in HIV-infected patients initiating highly active antiretroviral therapy with CD4 lymphocyte counts >350 lymphocytes/mm3.
Hulgan T; Raffanti S; Kheshti A; Blackwell RB; Rebeiro PF; Barkanic G; Ritz B; Sterling TR
J Infect Dis; 2005 Sep; 192(6):950-7. PubMed ID: 16107946
[TBL] [Abstract][Full Text] [Related]
3. Treatment initiation with zidovudine-containing potent antiretroviral therapy impairs CD4 cell count recovery but not clinical efficacy.
Huttner AC; Kaufmann GR; Battegay M; Weber R; Opravil M
AIDS; 2007 May; 21(8):939-46. PubMed ID: 17457087
[TBL] [Abstract][Full Text] [Related]
4. Microbial translocation is associated with sustained failure in CD4+ T-cell reconstitution in HIV-infected patients on long-term highly active antiretroviral therapy.
Marchetti G; Bellistrì GM; Borghi E; Tincati C; Ferramosca S; La Francesca M; Morace G; Gori A; Monforte AD
AIDS; 2008 Oct; 22(15):2035-8. PubMed ID: 18784466
[TBL] [Abstract][Full Text] [Related]
5. Untangling the immunological implications of nadir on CD4+ cell recovery during suppressive highly active antiretroviral therapy.
Ferraris L; Bellistri GM; Pegorer V; Tincati C; Meroni L; Galli M; Monforte Ad; Gori A; Marchetti G
Clin Infect Dis; 2008 Jan; 46(1):149-50. PubMed ID: 18171234
[No Abstract] [Full Text] [Related]
6. CD4 cell recovery in treated HIV-2-infected adults is lower than expected: results from the French ANRS CO5 HIV-2 cohort.
Matheron S; Damond F; Benard A; Taieb A; Campa P; Peytavin G; Pueyo S; Brun-Vezinet F; Chene G;
AIDS; 2006 Feb; 20(3):459-62. PubMed ID: 16439883
[TBL] [Abstract][Full Text] [Related]
7. Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era.
El Amari EB; Toutous-Trellu L; Gayet-Ageron A; Baumann M; Cathomas G; Steffen I; Erb P; Mueller NJ; Furrer H; Cavassini M; Vernazza P; Hirsch HH; Bernasconi E; Hirschel B;
AIDS; 2008 May; 22(9):1019-28. PubMed ID: 18520345
[TBL] [Abstract][Full Text] [Related]
8. [HIV infection: in the HAART era, CD4 makes the difference].
Varsky C
Acta Gastroenterol Latinoam; 2004; 34(3):117-9. PubMed ID: 15742925
[No Abstract] [Full Text] [Related]
9. Low CD4+ T cell nadir is an independent predictor of lower HIV-specific immune responses in chronically HIV-1-infected subjects receiving highly active antiretroviral therapy.
Siddique MA; Hartman KE; Dragileva E; Dondero M; Gebretsadik T; Shintani A; Peiperl L; Valentine F; Kalams SA
J Infect Dis; 2006 Sep; 194(5):661-5. PubMed ID: 16897665
[TBL] [Abstract][Full Text] [Related]
10. CD4 T cell measurements in the management of antiretroviral therapy--A review with an emphasis on pediatric HIV-infected patients.
O'Gorman MR; Zijenah LS
Cytometry B Clin Cytom; 2008; 74 Suppl 1():S19-26. PubMed ID: 18228562
[TBL] [Abstract][Full Text] [Related]
11. Effect of early initiation of highly active antiretroviral therapy on CD4 cell count and HIV-RNA viral load trends within 24 months of the onset of acute retroviral syndrome.
Voirin N; Routy JP; Smith D; Baratin D; Trépo C; Cotte L; Touraine JL; Livrozet JM; Cooper DA; Ritter J; André P; Vanhems P
HIV Med; 2008 Jul; 9(6):440-4. PubMed ID: 18705761
[TBL] [Abstract][Full Text] [Related]
12. Decreasing CD4+ T-cell count during suppressed or low-level viraemia in patients with HIV infection.
Anderson AM; Kosinski AS; Bartlett JA
Antivir Ther; 2007; 12(7):1041-8. PubMed ID: 18018762
[TBL] [Abstract][Full Text] [Related]
13. Total lymphocyte count: a surrogate marker for predicting CD4+ count in enrolled process for antiretroviral therapy in resource-limited settings.
Susaengrat W; Mitchai M; Leerattanapetch N
J Med Assoc Thai; 2008 Oct; 91(10):1514-7. PubMed ID: 18972893
[TBL] [Abstract][Full Text] [Related]
14. Setting a minimum threshold CD4 count for initiation of highly active antiretroviral therapy in HIV-infected patients.
Ho C; Lee S; Wong Kh; Cheng L; Lam M
HIV Med; 2007 Apr; 8(3):181-5. PubMed ID: 17461862
[TBL] [Abstract][Full Text] [Related]
15. The use of total lymphocyte count (TLC) as an independent criterion for initiating HAART in resource-poor countries.
Lee SS; Wong KH
J Infect; 2005 Jan; 50(1):66-7. PubMed ID: 15603843
[TBL] [Abstract][Full Text] [Related]
16. Predictors of clinical progression among HIV-1-positive patients starting HAART with CD4+ T-cell counts > or =200 cells/mm3.
Lapadula G; Torti C; Maggiolo F; Casari S; Suter F; Minoli L; Pezzoli C; Di Pietro M; Migliorino G; Ouiros-Roldan E; Ladisa N; Sighinolfi L; Costarelli S; Carosi G;
Antivir Ther; 2007; 12(6):941-7. PubMed ID: 17926648
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a manual CD4+ count kit for determination of absolute CD4+ T-lymphocyte counts.
Mitchai M; Susaengrat W; Krissadarak K; Mitchai J; Leeratanapetch N
J Med Assoc Thai; 2008 Oct; 91(10):1495-8. PubMed ID: 18972890
[TBL] [Abstract][Full Text] [Related]
18. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression.
Moore RD; Keruly JC
Clin Infect Dis; 2007 Feb; 44(3):441-6. PubMed ID: 17205456
[TBL] [Abstract][Full Text] [Related]
19. Relationship of frequency of CD4+CD25+Foxp3+ regulatory T cells with disease progression in antiretroviral-naive HIV-1 infected Chinese.
Zhang Z; Jiang Y; Zhang M; Shi W; Liu J; Han X; Wang Y; Jin X; Shang H
Jpn J Infect Dis; 2008 Sep; 61(5):391-2. PubMed ID: 18806350
[TBL] [Abstract][Full Text] [Related]
20. Risks of non-accidental mortality by baseline CD4+ T-cell strata in hepatitis-C-positive and -negative individuals initiating highly active antiretroviral therapy.
Moore DM; Hogg RS; Braitstein P; Wood E; Yip B; Montaner JS
Antivir Ther; 2006; 11(1):125-9. PubMed ID: 16518968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
